Status:
UNKNOWN
EndoSearch : Endometriosis Biomarkers
Lead Sponsor:
Dr Afchine Fazel
Conditions:
Endometriosis (Diagnosis)
Blood Biomarkers
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
EndoSearch aims to analytically validate a cluster of specific biomarkers for endometriosis diagnosis and disease recurrence. This signature will be tested on endometrium and blood from 975 patients, ...
Detailed Description
Endometriosis is a very common gynecological disease affecting 10% of women of reproductive age. Main symptoms are chronic and severe pain in pelvis area and infertility in up to 40% of affected women...
Eligibility Criteria
Inclusion
- Inclusion Criteria for endometriosis patients :
- Woman, from 18 to 45
- Patients with endometriosis suspicion, associated adenomyosis is accepted
- Freely signature of the consent form
- Patient needs laparoscopy for endometriosis purpose (first intervention or recurrence) regardless of the endometriosis type (superficial, ovarian or deep)
- Possibility of follow up during 2 years.
- Inclusion Criteria for Healthy voluntary patients:
- Woman 18 to 45
- Freely signature of the consent form
- Patient needs laparoscopy for another indication than endometriosis, adenomyosis, uterine fibroma \& other fibroid pathologies (ex of surgeries: tubular sterilization, ovarian non-fibroid cyst, urinary incontinence requiring ureteral intervention).
- Exclusion Criteria for endometriosis patients :
- Refusal or linguistic or psychic incapacity to sign informed consent
- No internet access or refusal to use new technologies
- Minor woman (under 18 years old)
- Pregnancy or breastfeeding
- Menopause
- Evidence of adenomyosis without endometriosis
- All metabolic pathology, endocrine, chronical infectious or malignant.
- Endometriosis negative result at visual and histological examination by anatomopathologist of the clinical centre.
- Exclusion Criteria for Healthy voluntary patients
- Refusal or linguistic or psychic incapacity to sign informed consent
- No internet access or refusal to use new technologies
- Minor woman (under 18 years old)
- Pregnancy or breastfeeding
- Menopause
- Adenomyosis
- All metabolic pathology, endocrine, chronical infectious or malignant.
- Endometriosis positive result at visual and histological examination by anatomopathologist of the clinical centre.
Exclusion
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
975 Patients enrolled
Trial Details
Trial ID
NCT03376451
Start Date
January 1 2018
End Date
December 31 2022
Last Update
May 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Endodiag
Paris, France, 75014